Extraintestinal Manifestations in Vedolizumab and Anti-TNF-Treated Patients With Inflammatory Bowel Disease-Reference-Cited by-同舟云学术

Extraintestinal Manifestations in Vedolizumab and Anti-TNF-Treated Patients With Inflammatory Bowel Disease

Published:2018-04-13 Issue:9 Volume:24 Page:1876-1882
ISSN:1078-0998
Container-title:Inflammatory Bowel Diseases
language:en
Short-container-title:

Author:

Dubinsky Marla C¹,Cross Raymond K²,Sandborn William J³,Long Millie⁴,Song Xue⁵,Shi Nianwen⁵,Ding Yao⁵,Eichner Samantha⁶,Pappalardo Brandee⁶,Ganguli Arijit⁶,Wang Anthony⁶

Affiliation:

1. Icahn School of Medicine, Mount Sinai, New York, New York

2. University of Maryland School of Medicine, Baltimore, Maryland

3. University of California San Diego, La Jolla, California

4. Universtiy of North Carolina, Chapel Hill, Chapel Hill, North Carolina

5. Truven Health Analytics, Cambridge, Massachusetts

6. AbbVie Inc., North Chicago, Illinois

Funder

AbbVie

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,Immunology and Allergy

Link

http://academic.oup.com/ibdjournal/article-pdf/24/9/1876/25502265/izy065.pdf

Reference24 articles.

1. A comprehensive review of inflammatory bowel disease focusing on surgical management;Baik;J Korean Soc Coloproctol,2012

2. Comorbidity in inflammatory bowel disease;Román;World J Gastroenterol,2011

3. Extraintestinal manifestations of inflammatory bowel disease;Ardizzone;Dig Liver Dis,2008

4. Extraintestinal manifestations of inflammatory bowel disease;Levine;Gastroenterol Hepatol (N Y),2011

5. Extraintestinal manifestations of inflammatory bowel disease: epidemiology, diagnosis, and management;Larsen;Ann Med,2010

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ophthalmic Complications in Inflammatory Bowel Disease;Canadian IBD Today;2024-09-11

2. Pyoderma Gangrenosum in an Ulcerative Colitis Patient on Vedolizumab;Cureus;2024-09-11

3. Targeted therapies for uveitis in spondyloarthritis: A narrative review;Joint Bone Spine;2024-09

4. Initiation of vedolizumab did not provoke new‐onset spondylarthritis in patients with inflammatory bowel disease: A prospective 24‐week study with imaging assessments;United European Gastroenterology Journal;2024-07-04

5. The impact of vedolizumab therapy on extraintestinal manifestations in patients with inflammatory bowel disease: A systematic review and meta‐analysis;Journal of Gastroenterology and Hepatology;2024-05-13